5
President Donald Trump this week launched TrumpRx, a government-backed platform aimed at lowering prescription drug prices for Americans paying out of pocket. While the announcement initially raised concerns about pricing pressure, financial markets have delivered a clear response.
Major pharmaceutical stocks rallied on February 6, signaling that investors do not see TrumpRx as a near-term threat to earnings. That reaction also matters for broader markets, including crypto, because it shapes overall risk…
